跳至主要内容
临床试验/CTRI/2026/02/104059
CTRI/2026/02/104059尚未招募不适用

Clinical effect of jawarish bisbasa versus jawarish falafali in patients with subclinical hypothyroidism: A randomized comparative parallel clinical trial.

Dr Shaikh Sofia Tarannum1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2026年2月27日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
60
试验地点
1

研究概览

简要总结

This study is an open label , randomized, parallel group trial for the evaluation and comparison of two unani compound formulations Jawarish bisbasa and Jawarish falafali in the management of subclinical hypothyroidism. Jawarish bisbasa is given orally 5 gram twice a day after meal with lukewarm water for 90 days in 30 patients. Jawarish falafali is also given 5 gram twice a day with lukewarm water for 90 days in 30 patients of  comparative parallel group. The study will be conducted in Government Tibbi College and Hospital Kadam Kuan Patna Bihar.

Primary outcomes will be reduction in subjective parameters such as weight gain, cold intolerance, lethargy and constipation. There will also be reduction in TSH level and complete thyroid profile before and after trial.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
20.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Clinically diagnosed subjects of subclinical hypothyroidism.
  • Subjects having TSH level more than 5.5 micro IU/ ml and less than 15 micro IU/ml.

排除标准

  • Subjects on iodine containing vitamins or minerals.
  • Subjects suffering with any chronic medical illness like DM, HTN, IHD, Heart Failure, CKD, RA etc.
  • Subjects with other than Subclinical Hypothyroidism, Myxoedema, Hashimoto’s thyroiditis, Riedel’s thyroiditis, Hyperthyroidism etc.
  • Subjects who fail to give consent.

研究者

发起方
Dr Shaikh Sofia Tarannum
申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Dr Shaikh Sofia Tarannum

Government Tibbi College and Hospital Kadam Kuan Patna

研究点 (1)

Loading locations...

相似试验